Holdings of iShares Biotechnology ETF
iShares Trust · 246 declared positions · as of Mar 31, 2026
Original filing · Net assets 8.1B $ · Ten largest lines: 47.4 % of the equity sleeve
Sector breakdown
- Health care 50.8 %
- Materials 1.7 %
- Industrials 1.1 %
- Unattributed 46.4 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 88.9 %
- NL 3.4 %
- DK 2.1 %
- BM 1.2 %
- CA 0.8 %
- DE 0.7 %
- IE 0.6 %
- FR 0.5 %
- CH 0.4 %
- KY 0.4 %
- SG 0.1 %
- JE 0.1 %
- Other countries 0.6 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|---|---|---|
| US | 208 | 7.2B $ | 88.91 % |
| NL | 4 | 279.1M $ | 3.44 % |
| DK | 2 | 173.1M $ | 2.13 % |
| BM | 1 | 100.9M $ | 1.24 % |
| CA | 4 | 67.1M $ | 0.83 % |
| DE | 1 | 53.3M $ | 0.66 % |
| IE | 3 | 50.9M $ | 0.63 % |
| FR | 2 | 42M $ | 0.52 % |
| CH | 3 | 35.3M $ | 0.44 % |
| KY | 5 | 34.8M $ | 0.43 % |
| SG | 1 | 8.5M $ | 0.11 % |
| JE | 1 | 8.3M $ | 0.10 % |
Positions
| Company | Shares | Value | Weight |
|---|---|---|---|
| Gilead Sciences Inc | 4,515,707 | 629.4M $ | 7.75 % |
| Amgen Inc | 1,733,148 | 609.8M $ | 7.51 % |
| Vertex Pharmaceuticals Inc | 1,354,033 | 604.6M $ | 7.44 % |
| Regeneron Pharmaceuticals, Inc. | 758,232 | 585.8M $ | 7.21 % |
| Alnylam Pharmaceuticals Inc | 979,642 | 324.1M $ | 3.99 % |
| Insmed Inc | 1,587,887 | 259.7M $ | 3.20 % |
| Argenx SE | 341,883 | 249.7M $ | 3.07 % |
| Biogen Inc | 1,091,046 | 200M $ | 2.46 % |
| Natera Inc | 980,622 | 196.1M $ | 2.41 % |
| United Therapeutics Corp | 315,509 | 187.1M $ | 2.30 % |
| BEONE MEDICINES LTD | 529,143 | 157.1M $ | 1.93 % |
| Incyte Corp | 1,467,923 | 138.2M $ | 1.70 % |
| Moderna Inc | 2,692,459 | 136.8M $ | 1.68 % |
| Illumina Inc | 1,107,291 | 136.5M $ | 1.68 % |
| Revolution Medicines Inc | 1,283,912 | 124.9M $ | 1.54 % |
| Roivant Sciences Ltd | 3,642,557 | 100.9M $ | 1.24 % |
| Neurocrine Biosciences Inc | 727,502 | 95.8M $ | 1.18 % |
| Genmab A/S | 3,555,098 | 95.4M $ | 1.17 % |
| Bridgebio Pharma Inc | 1,238,687 | 92M $ | 1.13 % |
| Ionis Pharmaceuticals Inc | 1,205,549 | 90.5M $ | 1.11 % |
| Medpace Holdings Inc | 169,922 | 81.6M $ | 1.00 % |
| Madrigal Pharmaceuticals Inc | 155,341 | 81.3M $ | 1.00 % |
| Exelixis Inc | 1,871,326 | 80.3M $ | 0.99 % |
| BioMarin Pharmaceutical Inc | 1,412,330 | 79.8M $ | 0.98 % |
| Ascendis Pharma A/S | 339,948 | 77.8M $ | 0.96 % |
| Praxis Precision Medicines Inc | 195,097 | 62.9M $ | 0.77 % |
| Charles River Laboratories International Inc | 362,165 | 62.5M $ | 0.77 % |
| Arrowhead Pharmaceuticals Inc | 975,175 | 61.1M $ | 0.75 % |
| Vaxcyte Inc | 1,045,695 | 60.8M $ | 0.75 % |
| Bio-Techne Corp | 1,151,950 | 60.2M $ | 0.74 % |
| Cytokinetics Inc | 896,972 | 59.1M $ | 0.73 % |
| Halozyme Therapeutics Inc | 868,502 | 56.1M $ | 0.69 % |
| Axsome Therapeutics Inc | 319,088 | 53.9M $ | 0.66 % |
| BioNTech SE | 599,506 | 53.3M $ | 0.66 % |
| Krystal Biotech Inc | 188,966 | 48.8M $ | 0.60 % |
| Protagonist Therapeutics Inc | 447,047 | 47.1M $ | 0.58 % |
| Repligen Corp | 396,896 | 46.8M $ | 0.58 % |
| Kymera Therapeutics Inc | 521,385 | 43.4M $ | 0.53 % |
| Alkermes PLC | 1,216,662 | 43M $ | 0.53 % |
| Rhythm Pharmaceuticals Inc | 474,539 | 41.3M $ | 0.51 % |
| Abivax SA | 367,461 | 40.9M $ | 0.50 % |
| PTC Therapeutics Inc | 593,152 | 40.4M $ | 0.50 % |
| Cogent Biosciences Inc | 1,009,396 | 38.9M $ | 0.48 % |
| Arcellx Inc | 335,814 | 38.6M $ | 0.47 % |
| Terns Pharmaceuticals Inc | 713,848 | 37.6M $ | 0.46 % |
| Nuvalent Inc | 355,481 | 36.4M $ | 0.45 % |
| Mirum Pharmaceuticals Inc | 392,677 | 36.3M $ | 0.45 % |
| Tempus AI Inc | 773,906 | 35M $ | 0.43 % |
| Xenon Pharmaceuticals Inc | 598,390 | 34.8M $ | 0.43 % |
| Amicus Therapeutics Inc | 2,307,725 | 33.4M $ | 0.41 % |
| CRISPR Therapeutics AG | 663,733 | 31.6M $ | 0.39 % |
| Apellis Pharmaceuticals Inc | 778,245 | 31.3M $ | 0.39 % |
| Apogee Therapeutics Inc | 353,520 | 29.8M $ | 0.37 % |
| Scholar Rock Holding Corp | 593,730 | 29.2M $ | 0.36 % |
| ACADIA Pharmaceuticals Inc | 1,251,241 | 27.9M $ | 0.34 % |
| Bruker Corp | 764,342 | 27.6M $ | 0.34 % |
| Crinetics Pharmaceuticals Inc | 726,428 | 26.4M $ | 0.32 % |
| CG oncology Inc | 379,295 | 25.7M $ | 0.32 % |
| Spyre Therapeutics Inc | 478,909 | 24.2M $ | 0.30 % |
| Erasca Inc | 1,384,399 | 22.4M $ | 0.28 % |
| Tarsus Pharmaceuticals Inc | 297,522 | 20.9M $ | 0.26 % |
| Twist Bioscience Corp | 436,795 | 20.8M $ | 0.26 % |
| CENTESSA PHARMACEUTICALS PLC | 520,762 | 20.7M $ | 0.25 % |
| Ideaya Biosciences Inc | 615,636 | 20.5M $ | 0.25 % |
| Denali Therapeutics Inc | 1,055,210 | 20.3M $ | 0.25 % |
| Travere Therapeutics Inc | 674,600 | 20M $ | 0.25 % |
| ImmunityBio Inc | 2,572,701 | 19.7M $ | 0.24 % |
| Arcutis Biotherapeutics Inc | 814,779 | 19.2M $ | 0.24 % |
| Veracyte Inc | 579,343 | 18.7M $ | 0.23 % |
| Structure Therapeutics Inc | 381,676 | 18.4M $ | 0.23 % |
| Edgewise Therapeutics Inc | 572,192 | 18M $ | 0.22 % |
| 10X Genomics Inc | 841,716 | 17.9M $ | 0.22 % |
| LEGEND BIOTECH CORP | 983,928 | 17.8M $ | 0.22 % |
| Newamsterdam Pharma Co NV | 537,784 | 17.2M $ | 0.21 % |
| Vera Therapeutics Inc | 419,778 | 16.9M $ | 0.21 % |
| Dyne Therapeutics Inc | 917,470 | 16.6M $ | 0.20 % |
| Beam Therapeutics Inc | 692,124 | 16.5M $ | 0.20 % |
| BioCryst Pharmaceuticals Inc | 1,715,826 | 16.3M $ | 0.20 % |
| Kodiak Sciences Inc | 422,431 | 16.1M $ | 0.20 % |
| Sarepta Therapeutics Inc | 739,607 | 16.1M $ | 0.20 % |
| Caris Life Sciences Inc | 898,011 | 16.1M $ | 0.20 % |
| Immunovant Inc | 626,211 | 15.6M $ | 0.19 % |
| ADMA Biologics Inc | 1,711,239 | 15.4M $ | 0.19 % |
| Adaptive Biotechnologies Corp | 1,105,997 | 15.4M $ | 0.19 % |
| Summit Therapeutics Inc | 799,477 | 15.2M $ | 0.19 % |
| Oruka Therapeutics Inc | 304,331 | 14.9M $ | 0.18 % |
| Syndax Pharmaceuticals Inc | 631,524 | 14.8M $ | 0.18 % |
| Tango Therapeutics Inc | 687,885 | 14.4M $ | 0.18 % |
| Ultragenyx Pharmaceutical Inc | 680,286 | 14.3M $ | 0.18 % |
| Disc Medicine Inc | 214,889 | 13.7M $ | 0.17 % |
| Agios Pharmaceuticals Inc | 400,087 | 13.5M $ | 0.17 % |
| GRAIL Inc | 261,045 | 13.5M $ | 0.17 % |
| Definium Therapeutics Inc | 703,030 | 13.3M $ | 0.16 % |
| Zymeworks Inc | 529,981 | 13.3M $ | 0.16 % |
| Arcus Biosciences Inc | 612,355 | 13.2M $ | 0.16 % |
| Aurinia Pharmaceuticals Inc | 874,336 | 13M $ | 0.16 % |
| Enliven Therapeutics Inc | 322,556 | 12.6M $ | 0.16 % |
| Day One Biopharmaceuticals Inc | 578,773 | 12.4M $ | 0.15 % |
| Vericel Corp | 373,502 | 12M $ | 0.15 % |
| Mineralys Therapeutics Inc | 439,648 | 11.9M $ | 0.15 % |
| Alumis Inc | 530,358 | 11.7M $ | 0.14 % |
| ZAI LAB LTD | 613,747 | 11.5M $ | 0.14 % |
| Nurix Therapeutics Inc | 720,848 | 11.2M $ | 0.14 % |
| Stoke Therapeutics Inc | 331,288 | 10.8M $ | 0.13 % |
| Intellia Therapeutics Inc | 835,337 | 10.7M $ | 0.13 % |
| AnaptysBio Inc | 192,136 | 10.7M $ | 0.13 % |
| Recursion Pharmaceuticals Inc | 3,419,857 | 10.5M $ | 0.13 % |
| Tyra Biosciences Inc | 272,474 | 10.4M $ | 0.13 % |
| Relay Therapeutics Inc | 980,266 | 9.8M $ | 0.12 % |
| Amylyx Pharmaceuticals Inc | 687,536 | 9.6M $ | 0.12 % |
| Novavax Inc | 1,157,114 | 9.4M $ | 0.12 % |
| Iovance Biotherapeutics Inc | 2,619,021 | 9.2M $ | 0.11 % |
| WaVe Life Sciences Ltd | 1,176,186 | 8.5M $ | 0.11 % |
| Immunocore Holdings PLC | 277,185 | 8.4M $ | 0.10 % |
| Novocure Ltd | 763,201 | 8.3M $ | 0.10 % |
| Galapagos NV | 271,893 | 8.2M $ | 0.10 % |
| Grifols SA | 976,161 | 7.8M $ | 0.10 % |
| Biohaven Ltd | 917,535 | 7.8M $ | 0.10 % |
| Nuvation Bio Inc | 1,795,888 | 7.7M $ | 0.09 % |
| AtaiBeckley Inc | 2,160,067 | 7.6M $ | 0.09 % |
| Taysha Gene Therapies Inc | 1,672,180 | 7.5M $ | 0.09 % |
| Sionna Therapeutics Inc | 185,101 | 7.4M $ | 0.09 % |
| Trevi Therapeutics Inc | 608,481 | 7.3M $ | 0.09 % |
| Mesoblast Ltd. | 460,143 | 7.1M $ | 0.09 % |
| Corvus Pharmaceuticals Inc | 473,326 | 6.9M $ | 0.09 % |
| Olema Pharmaceuticals Inc | 457,751 | 6.8M $ | 0.08 % |
| Rapport Therapeutics Inc | 217,759 | 6.8M $ | 0.08 % |
| uniQure NV | 413,699 | 6.8M $ | 0.08 % |
| Geron Corp | 4,513,103 | 6.7M $ | 0.08 % |
| Fortrea Holdings Inc | 693,057 | 6.5M $ | 0.08 % |
| Vir Biotechnology Inc | 704,449 | 6.3M $ | 0.08 % |
| Xencor Inc | 513,267 | 6.2M $ | 0.08 % |
| AbCellera Biologics Inc | 1,732,022 | 6M $ | 0.07 % |
| MBX Biosciences Inc | 199,599 | 6M $ | 0.07 % |
| Maze Therapeutics Inc | 197,936 | 5.9M $ | 0.07 % |
| CareDx Inc | 337,886 | 5.9M $ | 0.07 % |
| Theravance Biopharma Inc | 353,652 | 5.7M $ | 0.07 % |
| Monte Rosa Therapeutics Inc | 346,430 | 5.7M $ | 0.07 % |
| KalVista Pharmaceuticals Inc | 276,916 | 5.6M $ | 0.07 % |
| Janux Therapeutics Inc | 392,349 | 5.5M $ | 0.07 % |
| Pharvaris NV | 191,961 | 5.4M $ | 0.07 % |
| MannKind Corp | 2,199,381 | 5.4M $ | 0.07 % |
| ORIC Pharmaceuticals Inc | 424,422 | 5.4M $ | 0.07 % |
| Castle Biosciences Inc | 215,689 | 5.3M $ | 0.07 % |
| Annexon Inc | 952,884 | 5.3M $ | 0.07 % |
| UroGen Pharma Ltd | 286,041 | 5.1M $ | 0.06 % |
| Kura Oncology Inc | 628,449 | 5.1M $ | 0.06 % |
| Inhibrx Biosciences Inc | 75,835 | 5.1M $ | 0.06 % |
| Stevanato Group SpA | 370,391 | 5.1M $ | 0.06 % |
| Arbutus Biopharma Corp | 1,119,437 | 5M $ | 0.06 % |
| Septerna Inc | 200,845 | 4.8M $ | 0.06 % |
| Alto Neuroscience Inc | 212,677 | 4.8M $ | 0.06 % |
| Bicara Therapeutics Inc | 236,865 | 4.7M $ | 0.06 % |
| GH RESEARCH PLC | 334,162 | 4.7M $ | 0.06 % |
| ArriVent Biopharma Inc | 201,242 | 4.6M $ | 0.06 % |
| CytomX Therapeutics Inc | 987,397 | 4.6M $ | 0.06 % |
| Cullinan Therapeutics Inc | 323,429 | 4.6M $ | 0.06 % |
| Replimune Group Inc | 570,930 | 4.4M $ | 0.05 % |
| Precigen Inc | 1,104,713 | 4.3M $ | 0.05 % |
| Arvinas Inc | 403,100 | 4.3M $ | 0.05 % |
| Savara Inc | 775,563 | 4.2M $ | 0.05 % |
| Ironwood Pharmaceuticals Inc | 1,173,471 | 4.1M $ | 0.05 % |
| Phathom Pharmaceuticals Inc | 356,945 | 4M $ | 0.05 % |
| Zevra Therapeutics Inc | 413,742 | 3.9M $ | 0.05 % |
| Cytek Biosciences Inc | 868,726 | 3.8M $ | 0.05 % |
| MeiraGTx Holdings plc | 430,643 | 3.7M $ | 0.05 % |
| ARS Pharmaceuticals Inc | 463,404 | 3.7M $ | 0.05 % |
| BioAge Labs Inc | 211,362 | 3.7M $ | 0.05 % |
| Sana Biotechnology Inc | 1,235,916 | 3.6M $ | 0.04 % |
| Rigel Pharmaceuticals Inc | 131,031 | 3.5M $ | 0.04 % |
| ZENAS BIOPHARMA INC | 175,941 | 3.4M $ | 0.04 % |
| Compass Pathways plc | 612,150 | 3.4M $ | 0.04 % |
| Fulcrum Therapeutics Inc | 429,371 | 3.3M $ | 0.04 % |
| OPKO Health, Inc. | 2,882,600 | 3.3M $ | 0.04 % |
| Solid Biosciences Inc | 446,552 | 3.2M $ | 0.04 % |
| 4D Molecular Therapeutics Inc | 338,744 | 3.2M $ | 0.04 % |
| Prothena Corp PLC | 323,349 | 3.1M $ | 0.04 % |
| Emergent BioSolutions Inc | 376,503 | 3.1M $ | 0.04 % |
| Myriad Genetics Inc | 662,895 | 3M $ | 0.04 % |
| Absci Corp | 975,088 | 2.9M $ | 0.04 % |
| BridgeBio Oncology Therapeutics Inc | 324,513 | 2.9M $ | 0.04 % |
| Perspective Therapeutics Inc | 693,460 | 2.9M $ | 0.04 % |
| Aclaris Therapeutics Inc | 766,012 | 2.9M $ | 0.04 % |
| Altimmune Inc | 926,610 | 2.9M $ | 0.04 % |
| Vanda Pharmaceuticals Inc | 405,038 | 2.8M $ | 0.03 % |
| Allogene Therapeutics Inc | 1,145,572 | 2.8M $ | 0.03 % |
| REGENXBIO Inc | 331,423 | 2.8M $ | 0.03 % |
| Rocket Pharmaceuticals Inc | 752,567 | 2.7M $ | 0.03 % |
| Pacific Biosciences of California Inc | 2,021,533 | 2.7M $ | 0.03 % |
| Lexeo Therapeutics Inc | 457,447 | 2.6M $ | 0.03 % |
| Alvotech SA | 763,481 | 2.6M $ | 0.03 % |
| Contineum Therapeutics Inc | 200,362 | 2.6M $ | 0.03 % |
| Enanta Pharmaceuticals Inc | 205,184 | 2.6M $ | 0.03 % |
| Lineage Cell Therapeutics Inc | 1,621,430 | 2.6M $ | 0.03 % |
| Standard BioTools Inc | 2,747,556 | 2.5M $ | 0.03 % |
| ADC Therapeutics SA | 673,142 | 2.5M $ | 0.03 % |
| Design Therapeutics Inc | 235,859 | 2.5M $ | 0.03 % |
| Personalis Inc | 393,153 | 2.5M $ | 0.03 % |
| Atea Pharmaceuticals Inc | 460,056 | 2.5M $ | 0.03 % |
| Prime Medicine Inc | 704,092 | 2.5M $ | 0.03 % |
| Keros Therapeutics Inc | 214,789 | 2.4M $ | 0.03 % |
| Fulgent Genetics Inc | 148,748 | 2.4M $ | 0.03 % |
| Tectonic Therapeutic Inc | 75,889 | 2.3M $ | 0.03 % |
| Aura Biosciences Inc | 338,128 | 2.3M $ | 0.03 % |
| Kyverna Therapeutics Inc | 251,263 | 2.2M $ | 0.03 % |
| Maravai LifeSciences Holdings Inc | 759,052 | 2.1M $ | 0.03 % |
| Immuneering Corp | 390,008 | 2.1M $ | 0.03 % |
| Anavex Life Sciences Corp | 668,447 | 2.1M $ | 0.03 % |
| Entrada Therapeutics Inc | 158,267 | 2M $ | 0.02 % |
| Ginkgo Bioworks Holdings Inc | 317,323 | 1.9M $ | 0.02 % |
| Upstream Bio Inc | 213,032 | 1.9M $ | 0.02 % |
| Neurogene Inc | 94,694 | 1.9M $ | 0.02 % |
| LENZ Therapeutics Inc | 206,971 | 1.9M $ | 0.02 % |
| Autolus Therapeutics PLC | 1,321,681 | 1.8M $ | 0.02 % |
| Editas Medicine Inc | 731,163 | 1.8M $ | 0.02 % |
| Cabaletta Bio Inc | 633,353 | 1.7M $ | 0.02 % |
| C4 Therapeutics Inc | 608,839 | 1.6M $ | 0.02 % |
| Larimar Therapeutics Inc | 350,415 | 1.6M $ | 0.02 % |
| Candel Therapeutics Inc | 294,995 | 1.4M $ | 0.02 % |
| Arcturus Therapeutics Holdings Inc | 186,967 | 1.4M $ | 0.02 % |
| OmniAb Inc | 874,147 | 1.4M $ | 0.02 % |
| NovaBridge Biosciences | 539,518 | 1.3M $ | 0.02 % |
| Voyager Therapeutics Inc | 329,043 | 1.3M $ | 0.02 % |
| AC Immune SA | 443,438 | 1.2M $ | 0.02 % |
| Bicycle Therapeutics PLC | 244,101 | 1.1M $ | 0.01 % |
| Caribou Biosciences Inc | 594,484 | 1.1M $ | 0.01 % |
| Codexis Inc | 683,417 | 1.1M $ | 0.01 % |
| Lyell Immunopharma Inc | 54,413 | 1.1M $ | 0.01 % |
| Cellectis SA | 339,873 | 1.1M $ | 0.01 % |
| Foghorn Therapeutics Inc | 223,190 | 1.1M $ | 0.01 % |
| Quanterix Corp | 284,827 | 1M $ | 0.01 % |
| Sagimet Biosciences Inc | 189,187 | 988.5K $ | 0.01 % |
| Quantum-Si Inc | 1,223,534 | 947K $ | 0.01 % |
| Silence Therapeutics PLC | 173,313 | 913.4K $ | 0.01 % |
| Tenaya Therapeutics Inc | 1,200,002 | 830.9K $ | 0.01 % |
| Neumora Therapeutics Inc | 421,430 | 821.8K $ | 0.01 % |
| PepGen Inc | 451,333 | 798.9K $ | 0.01 % |
| Humacyte Inc | 1,222,120 | 741.5K $ | 0.01 % |
| Black Diamond Therapeutics Inc | 321,542 | 684.9K $ | 0.01 % |
| Pyxis Oncology Inc | 345,130 | 503.9K $ | 0.01 % |
| Gossamer Bio Inc | 1,510,536 | 496.2K $ | 0.01 % |
| Jyong Biotech Ltd. | 206,499 | 444K $ | 0.01 % |
| Aardvark Therapeutics Inc | 89,682 | 338.1K $ | 0.00 % |
| Immutep Ltd | 809,244 | 284K $ | 0.00 % |
| Alpha Teknova Inc | 79,636 | 230.1K $ | 0.00 % |
| Third Harmonic Bio Inc | 134,478 | 1.3 $ |